Modern classification of neoplasms: reconciling differences between morphologic and molecular approaches

Area of Science:

• Oncology
• Genomics
• Developmental Biology

Background:

• Histomorphology has been the standard for neoplasm classification for over 150 years.
• Cancer genomics has introduced new classifications based on genetic alterations, challenging traditional methods.
• Discrepancies exist between morphologic and molecular approaches to tumor classification.

Purpose of the Study:

• To demonstrate how grouping tumors by developmental lineage can resolve fundamental discrepancies between morphologic and molecular classification.
• To highlight the clinical value of a robust tumor classification system.

Main Methods:

• The study examines six key issues in tumor classification that exemplify the rift between morphologic and molecular approaches.
• It discusses different methods of tumor classification, focusing on developmental lineage.

Main Results:

• Grouping neoplasms by embryologic origin (Developmental Lineage Classification and Taxonomy of Neoplasms) offers a unified approach.
• This classification is expected to reveal shared metabolic pathways and drug responses within tumors of common lineage.
• It addresses issues such as morphologic separation, shared cellular functions, germ cell vs. non-germ cell tumors, differentiation status, shared molecular properties in morphologically diverse tumors, and re-classification of clinically distinct subsets.

Conclusions:

• A scientifically sound neoplasm classification is crucial for designing targeted cancer therapies.
• Developmental lineage classification provides a framework for generalizing biological measurements and identifying tumor class-specific properties.
• This approach is essential for distinguishing meaningful data from noise in complex biological systems and advancing cancer medicine.